Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation
- 14 September 2007
- journal article
- clinical trial
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 40 (1), 25-32
- https://doi.org/10.1016/j.bcmd.2007.06.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationExperimental Hematology, 2006
- Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host DiseaseTransplantation, 2006
- Cell Culture Medium Composition and Translational Adult Bone Marrow‐Derived Stem Cell ResearchThe International Journal of Cell Cloning, 2006
- Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferationBlood, 2006
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2005
- Interactions Between Human Mesenchymal Stem Cells and Natural Killer CellsThe International Journal of Cell Cloning, 2005
- Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy PatientsTransplantation and Cellular Therapy, 2005
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptideBlood, 2003